|Articles|July 28, 2015
Janet Freeman-Daily on Genomic Testing for Lung Cancer Patients
Author(s)Janet Freeman-Daily
Janet Freeman-Daily, a patient with metastatic lung cancer and a CURE contributor, discusses the importance of genomic testing for patients with lung cancer.
Advertisement
Janet Freeman-Daily, a patient with metastatic lung cancer and a CURE contributor, discusses the importance of genomic testing for patients with lung cancer. We spoke with Freeman-Daily during the 2015 annual meeting of the American Society of Clinical Oncology (ASCO), a gathering of nearly 30,000 oncology professionals in Chicago.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on CURE
1
Inside the ‘Weird and Wacky’ Frontier of New Targeted Therapy for Lung Cancer
2
FDA Approves Epkinly Combo in Relapsed/Refractory Follicular Lymphoma
3
FDA Grants Fast Track Status to New Gastric Cancer Treatment
4
Understanding Emerging Cell Therapy in Lung Cancer
5
